Regulator, cos discuss price hike for some cancer drugs

India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin and cisplatin, are crucial for treating various cancers. The National Pharmaceutical Pricing Authority met with drug makers and hospital representatives to discuss the issue. Rising raw material costs have put pressure on production.

Raccontata daeconomictimes.indiatimes.com